107 related articles for article (PubMed ID: 1560437)
21. Effect of colestipol on gastrointestinal absorption of chlorothiazide in man.
Kauffman RE; Azarnoff DL
Clin Pharmacol Ther; 1973; 14(5):886-90. PubMed ID: 4729904
[No Abstract] [Full Text] [Related]
22. Probiotics--interactions with bile acids and impact on cholesterol metabolism.
Pavlović N; Stankov K; Mikov M
Appl Biochem Biotechnol; 2012 Dec; 168(7):1880-95. PubMed ID: 23054820
[TBL] [Abstract][Full Text] [Related]
23. Effects of colestipol, a new bile-acid-sequestering resin, on cholesterol metabolism in man.
Miller NE; Clifton-Bligh P; Nestel PJ
J Lab Clin Med; 1973 Dec; 82(6):876-90. PubMed ID: 4758739
[No Abstract] [Full Text] [Related]
24. Safety and efficacy of long-term diet and diet plus bile acid-binding resin cholesterol-lowering therapy in 73 children heterozygous for familial hypercholesterolemia.
Glueck CJ; Mellies MJ; Dine M; Perry T; Laskarzewski P
Pediatrics; 1986 Aug; 78(2):338-48. PubMed ID: 3526270
[TBL] [Abstract][Full Text] [Related]
25. The effect of colestipol hydrochloride on the bioavailability and pharmacokinetics of clofibrate.
DeSante KA; DiSanto AR; Albert KS; Weber DJ; Welch RD; Vecchio TJ
J Clin Pharmacol; 1979; 19(11-12):721-5. PubMed ID: 536468
[TBL] [Abstract][Full Text] [Related]
26. High dose of fluvastatin sodium (XU62-320), a new inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, lowers plasma cholesterol levels in homozygous Watanabe-heritable hyperlipidemic rabbits.
Kurokawa J; Hayashi K; Toyota Y; Shingu T; Shiomi M; Kajiyama G
Biochim Biophys Acta; 1995 Oct; 1259(1):99-104. PubMed ID: 7492622
[TBL] [Abstract][Full Text] [Related]
27. Anti-atherosclerotic activity of colestipol hydrochloride in SEA quail.
Day CE
Artery; 1990; 17(3):119-26. PubMed ID: 2337384
[TBL] [Abstract][Full Text] [Related]
28. Hypocholesterolemia of Rhizoma Coptidis alkaloids is related to the bile acid by up-regulated CYP7A1 in hyperlipidemic rats.
Cao Y; Bei W; Hu Y; Cao L; Huang L; Wang L; Luo D; Chen Y; Yao X; He W; Liu X; Guo J
Phytomedicine; 2012 Jun; 19(8-9):686-92. PubMed ID: 22554715
[TBL] [Abstract][Full Text] [Related]
29. Colestipol, clofibrate, and phytosterols in combined therapy of hyperlipidemia.
Grundy SM; Mok HY
J Lab Clin Med; 1977 Feb; 89(2):354-66. PubMed ID: 833472
[TBL] [Abstract][Full Text] [Related]
30. Bile acid sequestrants: glucose-lowering mechanisms.
Prawitt J; Staels B
Metab Syndr Relat Disord; 2010 Dec; 8 Suppl 1():S3-8. PubMed ID: 20977365
[TBL] [Abstract][Full Text] [Related]
31. S-8921, an ileal Na+/bile acid cotransporter inhibitor decreases serum cholesterol in hamsters.
Hara S; Higaki J; Higashino K; Iwai M; Takasu N; Miyata K; Tonda K; Nagata K; Goh Y; Mizui T
Life Sci; 1997; 60(24):PL 365-70. PubMed ID: 9188770
[TBL] [Abstract][Full Text] [Related]
32. Colestipol: a review of its pharmacological properties and therapeutic efficacy in patients with hypercholesterolaemia.
Heel RC; Brogden RN; Pakes GE; Speight TM; Avery GS
Drugs; 1980 Mar; 19(3):161-80. PubMed ID: 6988203
[TBL] [Abstract][Full Text] [Related]
33. Hypocholesterolemic properties of plant indoles. Inhibition of acyl-CoA:cholesterol acyltransferase activity and reduction of serum LDL/VLDL cholesterol levels by glucobrassicin derivatives.
Dunn SE; LeBlanc GA
Biochem Pharmacol; 1994 Jan; 47(2):359-64. PubMed ID: 8304980
[TBL] [Abstract][Full Text] [Related]
34. Intestinal absorption of cholesterol is mediated by a saturable, inhibitable transporter.
Hernandez M; Montenegro J; Steiner M; Kim D; Sparrow C; Detmers PA; Wright SD; Chao YS
Biochim Biophys Acta; 2000 Jul; 1486(2-3):232-42. PubMed ID: 10903474
[TBL] [Abstract][Full Text] [Related]
35. Mevinolin plus colestipol in therapy for severe heterozygous familial hypercholesterolemia.
Illingworth DR
Ann Intern Med; 1984 Nov; 101(5):598-604. PubMed ID: 6567462
[TBL] [Abstract][Full Text] [Related]
36. Managing dyslipidemia in the high-risk patient.
Stein EA
Am J Cardiol; 2002 Mar; 89(5A):50C-57C. PubMed ID: 11900720
[TBL] [Abstract][Full Text] [Related]
37. Inhibitors of acyl-CoA:cholesterol acyltransferase (ACAT). 7. Development of a series of substituted N-phenyl-N'-[(1-phenylcyclopentyl)methyl]ureas with enhanced hypocholesterolemic activity.
Trivedi BK; Purchase TS; Holmes A; Augelli-Szafran CE; Essenburg AD; Hamelehle KL; Stanfield RL; Bousley RF; Krause BR
J Med Chem; 1994 May; 37(11):1652-9. PubMed ID: 8201599
[TBL] [Abstract][Full Text] [Related]
38. Cholestipol hydrochloride, a new hypolipidemic drug: a two-year study-summary.
Cooper EE; Michel AM
Adv Exp Med Biol; 1977; 82():191-4. PubMed ID: 920358
[No Abstract] [Full Text] [Related]
39. In vitro adsorption of bile salts by colestipol hydrochloride.
Konechnik TJ; Kos R; White JL; Hem SL; Borin MT
Pharm Res; 1989 Jul; 6(7):619-23. PubMed ID: 2798312
[TBL] [Abstract][Full Text] [Related]
40. Regulation of biliary cholesterol secretion. Functional relationship between the canalicular and sinusoidal cholesterol secretory pathways in the rat.
Nervi F; Marinović I; Rigotti A; Ulloa N
J Clin Invest; 1988 Dec; 82(6):1818-25. PubMed ID: 3198756
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
